Clinical trial
Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open…
NCT00140062 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00140062 |
|---|---|
| Title | Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. |
| Official title | A Randomized Post-Marketing Efficacy And Safety Study Of Xalatan Compared With "Usual Care" Over 36 Months In Patients With Primary Open-Angle Glaucoma, Exfoliative Glaucoma Or Ocular Hypertension |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ocular Hypertension, Glaucoma, Open-Angle |
| Intervention type | Drug |
| Interventions | latanoprost 0.005% (Xalatan) |
| Enrollment | 329 |
| Start date | Feb 1, 2002 |
| Completion | Apr 1, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | Apr 7, 2008 |
| Countries | Finland, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: